Top Biotechnology companies in Belgium by Net Cash Used Provided By Financing Activities
Belgium
# |
Name |
Net Cash Used Provided By Financing Activities |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 32.28 M
|
Dec. 31, 2023 | USD 1.91 | 0.00% |
|
Belgium |
|
| 2 |
USD 18.61 M
|
Dec. 31, 2023 | USD 10.80 | 2.86% |
|
Belgium |
|
| 3 |
USD 14.86 M
|
Dec. 31, 2023 | USD 2.20 | -1.56% |
|
Belgium |
|
| 4 |
USD 6.10 M
|
Dec. 31, 2023 | USD 3.74 | -1.00% |
|
Belgium |
|
| 5 |
USD -5.52 M
|
Dec. 31, 2023 | USD 23.14 | 1.75% |
|
Belgium |
|
| 6 |
USD -15.88 M
|
Dec. 31, 2023 | USD 13.62 | -0.32% |
|
Belgium |
|
| 7 |
USD -62.94 M
|
Dec. 31, 2023 | USD 20.10 | 1.93% |
|
Belgium |
|
| 8 |
USD -339.95 M
|
Dec. 31, 2023 | USD 193.31 | -0.57% |
|
Belgium |
Frequently Asked Questions
-
Which Biotechnology company in Belgium has the highest Net Cash Used Provided By Financing Activities ?
The Biotechnology company in Belgium with the highest Net Cash Used Provided By Financing Activities is MDxHealth SA (NasdaqCM: MDXH) at USD 32.28 M.
-
Which Biotechnology company in Belgium has the lowest Net Cash Used Provided By Financing Activities ?
The Biotechnology company in Belgium with the lowest Net Cash Used Provided By Financing Activities is UCB SA (Brussels Stock Exchange: UCB.BR) at USD -339.95 M.
-
What are the top 10 Biotechnology companies in Belgium by Net Cash Used Provided By Financing Activities ?
The top 10 Biotechnology companies in Belgium by Net Cash Used Provided By Financing Activities are MDxHealth SA, Nyxoah S.A., Sequana Medical NV, Biotalys NV, Galapagos NV, Ion Beam Applications SA, Fagron NV and UCB SA.
-
What are the bottom 10 Biotechnology companies in Belgium by Net Cash Used Provided By Financing Activities ?
The bottom 10 Biotechnology companies in Belgium by Net Cash Used Provided By Financing Activities are UCB SA, Fagron NV, Ion Beam Applications SA, Galapagos NV, Biotalys NV, Sequana Medical NV, Nyxoah S.A. and MDxHealth SA.
